Difference between revisions of "Team:BGIC-Union/Parts"

Line 800: Line 800:
 
     </div>
 
     </div>
 
</nav> <!-- Slider start -->
 
</nav> <!-- Slider start -->
−
    <!-- Slider start -->
+
   
−
   
+
−
        <!-- PAGE CONTENT -->
+
<!-- +++++ Projects Section +++++ -->
−
        <div class="page-content">
+
<section>
−
            <div class="container">
+
−
                <section>
+
−
                    <div class="row">
+
           
−
                        <div class="col-md-6 parts collection">
+
<div class="container" >
−
<groupparts>BGIC-Union</groupparts>
+
−
<div class="highlight">
+
  
  
  
−
</p>
+
<div id="BasicParts">
−
<div id='groupparts' style='min-height:100px;width:700px;'><div style='width:300px;margin:2px;padding:20px;color:gray;border:1px solid gray'>Loading.....</div></div><script>$('#groupparts').load('/cgi/api/groupparts.cgi', { t:'iGEM17', g:'BGIC-Union' },function(){ $('#groupparts .tablesorter').tablesorter();} );</script>
+
−
<p>
+
−
</div>
+
−
</div>
+
−
                            </div>
+
−
                    </div>
+
−
                </section>
+
−
                <!-- END OUR CLIENTS -->
+
−
            </div>
+
−
        </div>
+
−
        <!-- END PAGE CONTENT -->
+
−
 
+
−
 
+
−
<div id=”basic parts”>
+
 
</br>
 
</br>
 
We create four Basic Biobricks regarding to T7-dCas9.</br>
 
We create four Basic Biobricks regarding to T7-dCas9.</br>
Line 841: Line 826:
 
</div>
 
</div>
 
</br>
 
</br>
−
<div id=”composite parts”>
+
<div id="CompositeParts">
  
 
We create seven composite Biobricks regarding to sgRNA. </br>
 
We create seven composite Biobricks regarding to sgRNA. </br>
 
We created a Biobrick for each of sgRNA and insert T7 promotor and T7 terminator before and after the sequence respectively in order to utilize them to transcribe sgRNA in vitro. The sequences are synthesize through Oligo DNA bridging designed by DNAworks. The detail of synthesis method is in the  
 
We created a Biobrick for each of sgRNA and insert T7 promotor and T7 terminator before and after the sequence respectively in order to utilize them to transcribe sgRNA in vitro. The sequences are synthesize through Oligo DNA bridging designed by DNAworks. The detail of synthesis method is in the  
 
experiment. </br>
 
experiment. </br>
−
+
</br></br><img src= "https://static.igem.org/mediawiki/2017/1/16/Pro6.jpg" width="600px"/></br></br>
−
Figure 1. The plasmid of sgRNA generator. The sgRNA generator Biobrick is composed of a T7 promotor, coding sequence for sgRNA and a T7 terminator.
+
 
 +
 
 +
<h6>Figure 1. The plasmid of sgRNA generator. The sgRNA generator Biobrick is composed of a T7 promotor, coding sequence for sgRNA and a T7 terminator.</h6>
 +
</br></br>
  
 
sgRNA generator for EML4-ALK Variant A 23  BBa_K2371004</br>
 
sgRNA generator for EML4-ALK Variant A 23  BBa_K2371004</br>
Line 869: Line 857:
 
   
 
   
 
<h6>Figure 2. The plasmid of pT7-RFP. pT7-RFP is composed of a T7 promotor, an RBS and the coding sequence of RFP. This plasmid is used to act as report gene in our report system.</h6>
 
<h6>Figure 2. The plasmid of pT7-RFP. pT7-RFP is composed of a T7 promotor, an RBS and the coding sequence of RFP. This plasmid is used to act as report gene in our report system.</h6>
−
</br></br><img src= “https://static.igem.org/mediawiki/2017/2/2a/Rfp.png” width=”600px”/></br></br>
+
</br></br><img src= "https://static.igem.org/mediawiki/2017/2/2a/Rfp.png" width="600px"/></br></br>
  
  
Line 875: Line 863:
 
<h6>Figure 3. The plasmid of pT7-amliGFP. pt7-amliGFP is composed of a T7 promotor, an RBS and the coding sequence of RFP. This plasmid is used to act as report gene in our report system.</h6>
 
<h6>Figure 3. The plasmid of pT7-amliGFP. pt7-amliGFP is composed of a T7 promotor, an RBS and the coding sequence of RFP. This plasmid is used to act as report gene in our report system.</h6>
 
</br></br>
 
</br></br>
−
<img src= “https://static.igem.org/mediawiki/2017/2/2a/Rfp.png” width=”600px”/></br></br>
+
<img src= "https://static.igem.org/mediawiki/2017/2/2a/Rfp.png" height="600px"/></br></br>
  
 
These two biobricks are supposed to cooperate with T7 PC report system in cell free system. The user need to conduct a PCR to linearize the part before reacting with T7 report system. When the split T7 polymerase reassemble, it will start transcription of GFP and RFP from these two plasmids.
 
These two biobricks are supposed to cooperate with T7 PC report system in cell free system. The user need to conduct a PCR to linearize the part before reacting with T7 report system. When the split T7 polymerase reassemble, it will start transcription of GFP and RFP from these two plasmids.
Line 882: Line 870:
 
We conducted both PCR check(VF and VR) and enzyme check(XbaI and SpeI) </br>
 
We conducted both PCR check(VF and VR) and enzyme check(XbaI and SpeI) </br>
  
−
</div>
+
</div></br></br>
−
+
<img src="" width="600px" />
−
 
+
Figure 4.PCR check of eforRed and amliGFP. The expected result of eforRed should be around 1000bp. The insufficient specificity of primers produce another band but the band around 1000bp can present the success of construction. The expected result of amliGFP should be around 1000bp. The control is J23119 biobrick.</h6></br></br>
  
 +
<img src="https://static.igem.org/mediawiki/2017/b/b0/Rdcheck.png" height="600px" />
 +
</br></br><h6>Figure 5.RD check of eforRed and amliGFP. XbaI and SpeI were used. The expected length of both amliGFP and eforRed should be around 750bp.</h6></br></br></br></br>
  
  
Line 896: Line 886:
 
   
 
   
  
−
<!-- +++++ Footer Section +++++ -->
+
 
−
+
 
 +
</div>
 +
 
 +
 
 +
 
 +
 +
</div>
 +
</section>
 +
<!-- +++++ Footer Section +++++ -->
 +
<section>
 
<div id="footer">
 
<div id="footer">
 
<div class="container">
 
<div class="container">
Line 911: Line 910:
 
 
 
<div class="col-lg-4">
 
<div class="col-lg-4">
−
<h4>Links</h4>
+
 
<p>
 
<p>
−
<a href="#">SAFETY</a><br/>
+
−
<a href="#">PARTS</a><br/>
+
<a href="https://2017.igem.org/Team:BGIC-Union/Applied_Design">Applied Design</a><br/>
−
<a href="#">EVALUATION</a>
+
<a href="https://2017.igem.org/Team:BGIC-Union/Entrepreneurship">Entreprenuership</a><br/>
 +
<a href="https://2017.igem.org/Team:BGIC-Union/Gold_Integrated">Integrated HP</a><br/>
 +
                      <a href="https://2017.igem.org/Team:BGIC-Union/Engagement">Education & Public Engagement</a><br/>
 +
  <a href="https://2017.igem.org/Team:BGIC-Union/Model">Model</a><br/>
 +
<a href="https://2017.igem.org/Team:BGIC-Union/Evaluation">EVALUATION</a>
 
</p>
 
</p>
 
</div><!-- /col-lg-4 -->
 
</div><!-- /col-lg-4 -->
Line 927: Line 930:
 
 
 
</div>
 
</div>
−
 
 
</div>
 
</div>
 
</div>
 
</div>
−
</div>
+
</section>
 +
 +
 
 +
 
 +
 
 
   </body>
 
   </body>
 +
 +
 +
 +
     
 +
 
</html>
 
</html>

Revision as of 10:58, 1 November 2017

Team：BGIC-Union


We create four Basic Biobricks regarding to T7-dCas9.
NT7-dCas9 BBa_K2371000
CT7-dCas9 BBa_K2371001
NT7 BBa_K2371002
CT7 BBa_K2371003

Description:


The first two Biobricks are the two split T7 polymerase sequence we adopted. We provide them for other team to leverage them through other methods. We choose the split site suggested by the team of Tiyun Han, Quan Chen and Haiyan Liu. [7]
The following two Biobricks are the sequence of T7 polymerase connected to dCas9 protein. The linker between split T7 polymerase and dCas9 is GGGGSGGGGS adopted by Peking University. A 6 X His-tag is added on C terminus of dCas9 in order to purify it.

We create seven composite Biobricks regarding to sgRNA.
We created a Biobrick for each of sgRNA and insert T7 promotor and T7 terminator before and after the sequence respectively in order to utilize them to transcribe sgRNA in vitro. The sequences are synthesize through Oligo DNA bridging designed by DNAworks. The detail of synthesis method is in the experiment.




Figure 1. The plasmid of sgRNA generator. The sgRNA generator Biobrick is composed of a T7 promotor, coding sequence for sgRNA and a T7 terminator.


sgRNA generator for EML4-ALK Variant A 23 BBa_K2371004
sgRNA generator for EML4-ALK Variant A 33 BBa_K2371005
sgRNA generator for EML4-ALK Variant A 83 BBa_K2371006
sgRNA generator for EML4-ALK Variant A 93 BBa_K2371007
sgRNA generator for EML4-ALK Variant B 70 BBa_K2371008
sgRNA generator for EML4-ALK Variant B 126 BBa_K2371009
sgRNA generator for EML4-ALK Variant B 147 BBa_K2371010

We create two supplemental composite biobricks for expression of GFP and RFP in cell free system.
pT7-eforRed BBa_K2371011
pT7-amilGFP BBa_K2371012
These two biobricks are composed of a T7 promotor with a coding sequence of GFP or RFP.
Figure 2. The plasmid of pT7-RFP. pT7-RFP is composed of a T7 promotor, an RBS and the coding sequence of RFP. This plasmid is used to act as report gene in our report system.




Figure 3. The plasmid of pT7-amliGFP. pt7-amliGFP is composed of a T7 promotor, an RBS and the coding sequence of RFP. This plasmid is used to act as report gene in our report system.




These two biobricks are supposed to cooperate with T7 PC report system in cell free system. The user need to conduct a PCR to linearize the part before reacting with T7 report system. When the split T7 polymerase reassemble, it will start transcription of GFP and RFP from these two plasmids.
We conducted both PCR check(VF and VR) and enzyme check(XbaI and SpeI)


Figure 4.PCR check of eforRed and amliGFP. The expected result of eforRed should be around 1000bp. The insufficient specificity of primers produce another band but the band around 1000bp can present the success of construction. The expected result of amliGFP should be around 1000bp. The control is J23119 biobrick.



Figure 5.RD check of eforRed and amliGFP. XbaI and SpeI were used. The expected length of both amliGFP and eforRed should be around 750bp.